Please ensure Javascript is enabled for purposes of website accessibility
Home > Products > Recombinant Proteins > Cytokines and Growth Factors

Human NGF/Beta-NGF Recombinant Protein (C-Fc) (HF909011)

Human NGF/Beta-NGF Recombinant Protein (C-Fc)
Human NGF/Beta-NGF Recombinant Protein (C-Fc)
Human NGF/Beta-NGF Recombinant Protein (C-Fc)
Human NGF/Beta-NGF Recombinant Protein (C-Fc)
Human NGF/Beta-NGF Recombinant Protein (C-Fc)
Human NGF/Beta-NGF Recombinant Protein (C-Fc)
Human NGF/Beta-NGF Recombinant Protein (C-Fc)
Human NGF/Beta-NGF Recombinant Protein (C-Fc)
Human NGF/Beta-NGF Recombinant Protein (C-Fc)
Human NGF/Beta-NGF Recombinant Protein (C-Fc)
Price(USD): $
Spec:
  • 50ug
  • 100ug
  • 1mg
Number:
Contact us
  • Overview

  • Images

  • References

  • Datasheet

  • SDS

Overview
Catalog No.HF909011
Description
Recombinant Human NGF/Beta-NGF Protein, C-Fc (HF909011) expressed in Mammalian Cells, spanning Ser122-Val238. Purity: >90% by SDS-PAGE.
Highlights
  • Fc Fusion — Enhanced stability with Protein A/G purification compatibility.
  • Mammalian Expression — Proper folding and native glycosylation.
  • High Purity — >90% purity verified by SDS-PAGE.
Expression systemMammalian Cells
AccessionP01138
Protein lengthSer122-Val238
ApplicationsELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
SpeciesHomo sapiens (Human)
Nature Recombinant
Endotoxin level Please contact with the lab for this information.
Purity >90% as determined by SDS-PAGE.
Form Lyophilized
Storage buffer Lyophilized from a solution in PBS pH 7.4, 1 mM EDTA, 4% Trehalose, 1% Mannitol.

Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.

Reconstitution Reconstitute in sterile water for a stock solution. Adjust the volume of sterile water so that, after reconstitution, the final stock concentration matches the value indicated on the product label or datasheet.

RECONSTITUTION PROTOCOL
1. Allow the product to be reconstituted and the reconstitution diluent to reach room temperature.
2. Tap or briefly centrifuge the product vial before opening to dislodge any lyophilized material that may be dispersed on the wall or cap of the vial.
3. Use the diluent and stock concentration recommended in the product datasheet. If preparing a stock concentration higher than recommended, contact Technical Service.
4. After adding the diluent, re-cap the vial and invert gently by hand or place on a slow rocking platform to allow the reconstitution diluent to coat all the surfaces inside the vial. Note: Do not mix by vortexing or by pipetting the material up and down.
5. Allow the vial to sit at room temperature with gentle agitation for at least 15 minutes before aliquotting or using.
6. Store the reconstituted material in single use aliquots in polypropylene or siliconized tubes. Aliquots of 10 μL or larger are recommended.
Shipping In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternate NamesBeta-nerve growth factor, NGFB, Beta-NGF, NGF
Background

Beta-nerve growth factor (NGF/Beta-NGF) is a ~26 kDa protein. Nerve growth factor is important for the development and maintenance of the sympathetic and sensory nervous systems. Extracellular ligand for the NTRK1 and NGFR receptors, activates cellular signaling cascades to regulate neuronal proliferation, differentiation and survival (Probable). The immature NGF precursor (proNGF) functions as a ligand for the heterodimeric receptor formed by SORCS2 and NGFR, and activates cellular signaling cascades that lead to inactivation of RAC1 and/or RAC2, reorganization of the actin cytoskeleton and neuronal growth cone collapse. In contrast to mature NGF, the precursor form (proNGF) promotes neuronal apoptosis (in vitro). Inhibits metalloproteinase-dependent proteolysis of platelet glycoprotein VI.

1. Einarsdottir, E. et al. (2004) Human molecular genetics 13, 799-805. PMID: 14976160
2. Carvalho, OP. et al. (2011) Journal of medical genetics 48, 131-5. PMID: 20978020
3. Wijeyewickrema, LC. et al. (2010) The Journal of biological chemistry 285, 11793-9. PMID: 20164177
Note For research use only.
Images
  • Human NGF/Beta-NGF Recombinant Protein (C-Fc)

    SDS-PAGE

    SDS-PAGE for Recombinant Human NGF/Beta-NGF Protein, C-Fc

  • Human NGF/Beta-NGF Recombinant Protein (C-Fc)

    Bioactivity

    Detected by Tanezumab (Catalog No: HF909016) in indirect ELISA.

  • Human NGF/Beta-NGF Recombinant Protein (C-Fc)

    Bioactivity

    Detected by Bedinvetmab (Catalog No: CF909016) in indirect ELISA.

  • Human NGF/Beta-NGF Recombinant Protein (C-Fc)

    Bioactivity

    Detected by Izenivetmab (Catalog No: CF909036) in indirect ELISA.

  • Human NGF/Beta-NGF Recombinant Protein (C-Fc)

    Western blot

    Detected by Anti-NGF/Beta-NGF monoclonal antibody (Catalog No: HF909010)

Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
Recommendation

Contact us for custom quotes, bulk requests and any other issues.

Mail: support@abinScience.com

Distributor list